Pharmerica Cash Flow - Annual (NYSE:PMC)

Add to My Stocks
$29.25 $0.05 (0.17%) PMC stock closing price Dec 07, 2017 (Closing)

The Pharmerica cash flow statement is one of the three reports that the company generates every quarter. Financials statements like the Pharmerica income statement and Pharmerica balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Pharmerica saw a cash impact of $-3.1M from the buyback of PMC shares. The cash flow statement helps in the Pharmerica stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Pharmerica saw a outflow of $-91.7M from investing activities for 2016.

View details of Pharmerica cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow58.1M52.3M42.3M37M31.9M31.9M28.7M27.4M28.9M
Net Increase (Decrease) in Assets Liabilities-64.39M-80.3M-11.6M79.6M17.9M-55.2M32.3M-9.3M5.09M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net15.5M11.4M10.9M20.2M13M26.7M18M24.7M26.7M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-34.1M-23.8M-25.5M-27.2M-20.5M-13M-12.5M-21.5M-21.5M
Acquisition Disposition of Subsidiaires-57.6M-83.6M-131.5M-26.5M-84.8M-51M-120.7M-54.7M-25.9M
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-3.3M-------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-3.1M-3.5M3.4M-6.3M-0.8M--10.3M1.4M1M
Issuance (Repayment) of Debt Securities46.8M76.5M118.7M-84.2M15.3M53.59M4.9M-0.6M-10M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.5M2.4M-4.4M---9.8M---
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year23.1M33.3M24.2M12.3M17.4M10.8M51.2M41.3M32M
Cash & Equivalents at Year End5.4M23.1M33.3M24.2M12.3M17.4M10.8M51.2M41.3M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

While Pharmerica stock price history provides the price history of a stock, Pharmerica stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Pharmerica has cash of $5.4M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Pharmerica stock price.
  • The cash generated from the core business or operations was a positive at $30.8M for Pharmerica in the latest 2016. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-91.7M for PMC in last 2016 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $43.2M for Pharmerica. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Pharmerica Cash Flow

FCF margin